Income Before Tax
Pre-Tax Income
Edwards Lifesciences Pre-Tax Income increased by 407.7% to $459.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.8%, from $433.90M to $459.00M. Over 4 years (FY 2021 to FY 2025), Pre-Tax Income shows a downward trend with a -7.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionIncome Before Tax
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
This provides a view of profitability that is not skewed by varying tax rates or one-time tax credits.
Detailed definition
A company's profits before the deduction of corporate income tax. It combines operating performance with non-operating f...
Peer comparison
Used to compare companies across different tax jurisdictions to see who generates more raw profit.
Metric ID:
income_before_taxHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $545.50M | $390.90M | $376.30M | $436.10M | $464.70M | $407.30M | $459.30M | $398.60M | $338.50M | $439.30M | $421.70M | $409.40M | $386.60M | $402.80M | $349.30M | $433.90M | $400.20M | $348.40M | $90.40M | $459.00M |
| QoQ Change | — | -28.3% | -3.7% | +15.9% | +6.6% | -12.4% | +12.8% | -13.2% | -15.1% | +29.8% | -4.0% | -2.9% | -5.6% | +4.2% | -13.3% | +24.2% | -7.8% | -12.9% | -74.1% | +407.7% |
| YoY Change | — | — | — | — | -14.8% | +4.2% | +22.1% | -8.6% | -27.2% | +7.9% | -8.2% | +2.7% | +14.2% | -8.3% | -17.2% | +6.0% | +3.5% | -13.5% | -74.1% | +5.8% |
Range$90.40M – $545.50M
CAGR-3.6%
Avg YoY Growth-6.6%
Median YoY Growth-2.7%
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| United States | $544.20M | $551.20M | $446.90M | $559.10M | $585.90M | $599.50M | $600.50M | $610.70M |
| Europe | $187.40M | $177.30M | $169.00M | $194.50M | $204.00M | $206.60M | $191.10M | $235.30M |
| Rest of World | $61.10M | $67.20M | $37.70M | $77.50M | $84.70M | $82.00M | $54.30M | $89.70M |
| Japan | $58.30M | $54.40M | $40.30M | $57.70M | $63.40M | $59.80M | $52.90M | $66.40M |
| Total | $386.60M | $402.80M | $349.30M | $433.90M | $400.20M | $348.40M | $90.40M | $459.00M |
Pre-Tax Income at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's pre-tax income?
- Edwards Lifesciences (EW) reported pre-tax income of $459.00M in Q1 2026.
- How has Edwards Lifesciences's pre-tax income changed year-over-year?
- Edwards Lifesciences's pre-tax income increased by 5.8% year-over-year, from $433.90M to $459.00M.
- What is the long-term trend for Edwards Lifesciences's pre-tax income?
- Over 4 years (2021 to 2025), Edwards Lifesciences's pre-tax income has grown at a -7.0% compound annual growth rate (CAGR), from $1.70B to $1.27B.
- What does pre-tax income mean?
- The total profit a company made before paying its income taxes.